Revenue Breakdown
Composition ()
No data
Revenue Streams
Aurora Cannabis Inc (ACB) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Cannabis, accounting for 87.2% of total sales, equivalent to CAD 78.81M. Another important revenue stream is Plant propagation. Understanding this composition is critical for investors evaluating how ACB navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Aurora Cannabis Inc maintains a gross margin of 5.93%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -38.00%, while the net margin is -1.85%. These profitability ratios, combined with a Return on Equity (ROE) of -15.06%, provide a clear picture of how effectively ACB converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ACB competes directly with industry leaders such as OGI and AFRI. With a market capitalization of $199.05M, it holds a significant position in the sector. When comparing efficiency, ACB's gross margin of 5.93% stands against OGI's 10.40% and AFRI's 9.75%. Such benchmarking helps identify whether Aurora Cannabis Inc is trading at a premium or discount relative to its financial performance.
